rs147463318
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001368809.2(AMPD2):c.23C>G(p.Ser8Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000628 in 1,608,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001368809.2 missense
Scores
Clinical Significance
Conservation
Publications
- pontocerebellar hypoplasia type 9Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics
- hereditary spastic paraplegia 63Inheritance: Unknown, AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AMPD2 | NM_001368809.2 | c.23C>G | p.Ser8Cys | missense_variant | Exon 2 of 19 | ENST00000528667.7 | NP_001355738.1 | |
| AMPD2 | NM_004037.9 | c.23C>G | p.Ser8Cys | missense_variant | Exon 1 of 18 | NP_004028.4 | ||
| AMPD2 | NM_001308170.1 | c.91C>G | p.Leu31Val | missense_variant | Exon 1 of 17 | NP_001295099.1 | ||
| AMPD2 | NM_139156.4 | c.10+920C>G | intron_variant | Intron 1 of 17 | NP_631895.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AMPD2 | ENST00000528667.7 | c.23C>G | p.Ser8Cys | missense_variant | Exon 2 of 19 | 1 | NM_001368809.2 | ENSP00000436541.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152242Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000254 AC: 6AN: 236170 AF XY: 0.0000156 show subpopulations
GnomAD4 exome AF: 0.0000646 AC: 94AN: 1455936Hom.: 0 Cov.: 34 AF XY: 0.0000511 AC XY: 37AN XY: 723700 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74370 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.185C>G (p.S62C) alteration is located in exon 1 (coding exon 1) of the AMPD2 gene. This alteration results from a C to G substitution at nucleotide position 185, causing the serine (S) at amino acid position 62 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Hereditary spastic paraplegia 63;C4014354:Pontocerebellar hypoplasia type 9 Uncertain:1
This sequence change replaces serine with cysteine at codon 62 of the AMPD2 protein (p.Ser62Cys). The serine residue is weakly conserved and there is a moderate physicochemical difference between serine and cysteine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with AMPD2-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at